Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Small Cell Lung Carcinoma × MLN 8237 × 30 days × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 1 Rhabdoid Tumor 1 Lymphoma, Mantle-Cell 1 Lymphoma, B-Cell 1 Breast Neoplasms 1

Interventions

Etoposide 12 Carboplatin 12 durvalumab 9 PM 01183 8 atezolizumab 6 pembrolizumab 5 Topotecan 5 Specimen Handling 4 Radiosurgery 4 Paclitaxel 4 Nivolumab 4 Ipilimumab 3 Drug Therapy 3 Bevacizumab 3 AMG 757 3 cabozantinib 2 berzosertib 2 Temozolomide 2 Radiotherapy 2 Magnetic Resonance Spectroscopy 2 Cisplatin 2 Biopsy 2 tremelimumab 1 trastuzumab deruxtecan 1 toripalimab 1 tazemetostat 1 talazoparib 1 surufatinib 1 stenoparib 1 sacituzumab govitecan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07465757 2026-03-12

ALISCA-Lung2

Puma Biotechnology, Inc.

Phase 2 Not yet recruiting

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡